NCT06920264View on ClinicalTrials.gov

Effect of Tranexamic Acid (TXA) Administered Prior to Shoulder Arthroscopy on Postoperative Pain Medication Usage: A Randomized Controlled Trial

PHASE1CompletedINTERVENTIONAL

Enrollment

165

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

September 8, 2024

Study Completion Date

September 30, 2024

Conditions

This Study Will Evaluate Whether TXA Reduces Pain

Interventions

DRUG

Tranexamic acid

A total of 150 participants will be enrolled and randomized 1:1 to receive either a standard dose of TXA (1000 mg) or an equivalent volume of placebo (normal saline, NS) at the time of surgery. .

OTHER

placebo

saline

Trial Locations (1)

63044

SSM Health- DePaul, Bridgeton

All Listed Sponsors

lead

St. Louis Joint Replacement Institute

OTHER